Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Nature Communications
|
September 27, 2019
c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression
Wen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, et al.
Nature Communications
|
November 10, 2019
Author Correction: c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression
Wen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, et al.
The Journal of Clinical Investigation
|
December 28, 2018
PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer
Roman M Chabanon, Gareth Muirhead, Dragomir B Krastev, et al.
European Urology
|
October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
J Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
The Journal of Clinical Investigation
|
May 3, 2022
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer
Mathieu Rouanne, Julien Adam, Camélia Radulescu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 7, 2023
Immune checkpoints are predominantly co-expressed by clonally expanded CD4<sup>+</sup>FoxP3<sup>+</sup> intratumoral T-cells in primary human cancers
Delphine Bredel, Edi Tihic, Séverine Mouraud, et al.
European Urology Oncology
|
May 26, 2026
Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process
Elke Rammant, Louis Fox, Silva De Padova, et al.
Cancer Discovery
|
January 20, 2023
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma
François-Xavier Danlos, Matthieu Texier, Bastien Job, et al.
EMBO Molecular Medicine
|
December 29, 2020
Immunodynamics of explanted human tumors for immuno-oncology
Agathe Dubuisson, Jean-Eudes Fahrner, Anne-Gaëlle Goubet, et al.
Cancer Discovery
|
August 5, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer
Anne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Nature Communications
|
September 27, 2019
c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression
Wen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, et al.
Nature Communications
|
November 10, 2019
Author Correction: c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression
Wen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, et al.
The Journal of Clinical Investigation
|
December 28, 2018
PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer
Roman M Chabanon, Gareth Muirhead, Dragomir B Krastev, et al.
European Urology
|
October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
J Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
The Journal of Clinical Investigation
|
May 3, 2022
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer
Mathieu Rouanne, Julien Adam, Camélia Radulescu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 7, 2023
Immune checkpoints are predominantly co-expressed by clonally expanded CD4<sup>+</sup>FoxP3<sup>+</sup> intratumoral T-cells in primary human cancers
Delphine Bredel, Edi Tihic, Séverine Mouraud, et al.
European Urology Oncology
|
May 26, 2026
Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process
Elke Rammant, Louis Fox, Silva De Padova, et al.
Cancer Discovery
|
January 20, 2023
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma
François-Xavier Danlos, Matthieu Texier, Bastien Job, et al.
EMBO Molecular Medicine
|
December 29, 2020
Immunodynamics of explanted human tumors for immuno-oncology
Agathe Dubuisson, Jean-Eudes Fahrner, Anne-Gaëlle Goubet, et al.
Cancer Discovery
|
August 5, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer
Anne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva, et al.
Page
of 6